Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.

Identifieur interne : 004A39 ( Main/Exploration ); précédent : 004A38; suivant : 004A40

Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.

Auteurs : Ji Hye Hwang [Corée du Sud] ; In Gul Kim ; Ji Young Lee ; Shuyu Piao ; David S. Lee ; Tae Seung Lee ; Jeong Chan Ra ; Ji Youl Lee

Source :

RBID : pubmed:21421266

Descripteurs français

English descriptors

Abstract

Lymphedema is a manifestation of lymphatic system insufficiency. It arises from primary lymphatic dysplasia or secondary obliteration after lymph node dissection or irradiation. Although improvement of swelling can be achieved by comprehensive non-operative therapy, treatment of this condition requires lifelong care and good compliance. Recently molecular-based treatments using VEGF-C have been investigated by several researchers. We designed the present study to determine whether the therapeutic efficacy of implanted human adipose-derived stem cells (hADSCs) could be improved by applying a gelatin hydrogel containing VEGF-C (VEGF-C hydrogel) to the site of tissue injury in a lymphedema mouse model. Four weeks after the operation, we evaluated edema and determined lymphatic vessel density at various post-operative time points. Mice treated with hADSCs and VEGF-C hydrogel showed a significantly decreased dermal edema depth compared to the groups of mice that received hADSCs only or VEGF-C hydrogel only. Immunohistochemical analysis also revealed that the hADSC/VEGF-C hydrogel group showed significantly greater lymphatic vessel regeneration than all the other groups. hADSCs were detected in the implantation sites of all mice in the hADSC/VEGF-C group, and exhibited a lymphatic endothelial differentiation phenotype as determined by co-staining PKH-labeled hADSCs for the lymphatic marker LYVE-1. Our results suggest that co-administration of hADSCs and VEGF-C hydrogel has a substantial positive effect on lymphangiogenesis.

DOI: 10.1016/j.biomaterials.2011.02.051
PubMed: 21421266


Affiliations:


Links toward previous steps (curation, corpus...)


Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.</title>
<author>
<name sortKey="Hwang, Ji Hye" sort="Hwang, Ji Hye" uniqKey="Hwang J" first="Ji Hye" last="Hwang">Ji Hye Hwang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kim, In Gul" sort="Kim, In Gul" uniqKey="Kim I" first="In Gul" last="Kim">In Gul Kim</name>
</author>
<author>
<name sortKey="Lee, Ji Young" sort="Lee, Ji Young" uniqKey="Lee J" first="Ji Young" last="Lee">Ji Young Lee</name>
</author>
<author>
<name sortKey="Piao, Shuyu" sort="Piao, Shuyu" uniqKey="Piao S" first="Shuyu" last="Piao">Shuyu Piao</name>
</author>
<author>
<name sortKey="Lee, David S" sort="Lee, David S" uniqKey="Lee D" first="David S" last="Lee">David S. Lee</name>
</author>
<author>
<name sortKey="Lee, Tae Seung" sort="Lee, Tae Seung" uniqKey="Lee T" first="Tae Seung" last="Lee">Tae Seung Lee</name>
</author>
<author>
<name sortKey="Ra, Jeong Chan" sort="Ra, Jeong Chan" uniqKey="Ra J" first="Jeong Chan" last="Ra">Jeong Chan Ra</name>
</author>
<author>
<name sortKey="Lee, Ji Youl" sort="Lee, Ji Youl" uniqKey="Lee J" first="Ji Youl" last="Lee">Ji Youl Lee</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2011">2011</date>
<idno type="RBID">pubmed:21421266</idno>
<idno type="pmid">21421266</idno>
<idno type="doi">10.1016/j.biomaterials.2011.02.051</idno>
<idno type="wicri:Area/PubMed/Corpus">002701</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002701</idno>
<idno type="wicri:Area/PubMed/Curation">002701</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002701</idno>
<idno type="wicri:Area/PubMed/Checkpoint">002701</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">002701</idno>
<idno type="wicri:Area/Ncbi/Merge">004214</idno>
<idno type="wicri:Area/Ncbi/Curation">004214</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004214</idno>
<idno type="wicri:Area/Main/Merge">004A71</idno>
<idno type="wicri:Area/Main/Curation">004A39</idno>
<idno type="wicri:Area/Main/Exploration">004A39</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.</title>
<author>
<name sortKey="Hwang, Ji Hye" sort="Hwang, Ji Hye" uniqKey="Hwang J" first="Ji Hye" last="Hwang">Ji Hye Hwang</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, Republic of Korea.</nlm:affiliation>
<country xml:lang="fr">Corée du Sud</country>
<wicri:regionArea>Department of Physical and Rehabilitation Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul</wicri:regionArea>
<placeName>
<settlement type="city">Séoul</settlement>
<region type="capital">Région capitale de Séoul</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Kim, In Gul" sort="Kim, In Gul" uniqKey="Kim I" first="In Gul" last="Kim">In Gul Kim</name>
</author>
<author>
<name sortKey="Lee, Ji Young" sort="Lee, Ji Young" uniqKey="Lee J" first="Ji Young" last="Lee">Ji Young Lee</name>
</author>
<author>
<name sortKey="Piao, Shuyu" sort="Piao, Shuyu" uniqKey="Piao S" first="Shuyu" last="Piao">Shuyu Piao</name>
</author>
<author>
<name sortKey="Lee, David S" sort="Lee, David S" uniqKey="Lee D" first="David S" last="Lee">David S. Lee</name>
</author>
<author>
<name sortKey="Lee, Tae Seung" sort="Lee, Tae Seung" uniqKey="Lee T" first="Tae Seung" last="Lee">Tae Seung Lee</name>
</author>
<author>
<name sortKey="Ra, Jeong Chan" sort="Ra, Jeong Chan" uniqKey="Ra J" first="Jeong Chan" last="Ra">Jeong Chan Ra</name>
</author>
<author>
<name sortKey="Lee, Ji Youl" sort="Lee, Ji Youl" uniqKey="Lee J" first="Ji Youl" last="Lee">Ji Youl Lee</name>
</author>
</analytic>
<series>
<title level="j">Biomaterials</title>
<idno type="eISSN">1878-5905</idno>
<imprint>
<date when="2011" type="published">2011</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Animals</term>
<term>Biocompatible Materials (chemistry)</term>
<term>Biocompatible Materials (metabolism)</term>
<term>Biocompatible Materials (therapeutic use)</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Gelatin (chemistry)</term>
<term>Humans</term>
<term>Hydrogel (chemistry)</term>
<term>Hydrogel (pharmacology)</term>
<term>Lymphangiogenesis</term>
<term>Lymphedema (therapy)</term>
<term>Materials Testing</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Regeneration (physiology)</term>
<term>Stem Cell Transplantation</term>
<term>Stem Cells (cytology)</term>
<term>Stem Cells (physiology)</term>
<term>Vascular Endothelial Growth Factor C (pharmacology)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Animaux</term>
<term>Cellules souches (cytologie)</term>
<term>Cellules souches (physiologie)</term>
<term>Facteur de croissance endothéliale vasculaire de type C (pharmacologie)</term>
<term>Femelle</term>
<term>Gélatine ()</term>
<term>Humains</term>
<term>Hydrogel ()</term>
<term>Hydrogel (pharmacologie)</term>
<term>Lymphangiogenèse</term>
<term>Lymphoedème ()</term>
<term>Matériaux biocompatibles ()</term>
<term>Matériaux biocompatibles (métabolisme)</term>
<term>Matériaux biocompatibles (usage thérapeutique)</term>
<term>Modèles animaux de maladie humaine</term>
<term>Régénération (physiologie)</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Test de matériaux</term>
<term>Transplantation de cellules souches</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Biocompatible Materials</term>
<term>Gelatin</term>
<term>Hydrogel</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Biocompatible Materials</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Hydrogel</term>
<term>Vascular Endothelial Growth Factor C</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en">
<term>Biocompatible Materials</term>
</keywords>
<keywords scheme="MESH" qualifier="cytologie" xml:lang="fr">
<term>Cellules souches</term>
</keywords>
<keywords scheme="MESH" qualifier="cytology" xml:lang="en">
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Matériaux biocompatibles</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Hydrogel</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr">
<term>Cellules souches</term>
<term>Régénération</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en">
<term>Regeneration</term>
<term>Stem Cells</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr">
<term>Matériaux biocompatibles</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Animals</term>
<term>Disease Models, Animal</term>
<term>Female</term>
<term>Humans</term>
<term>Lymphangiogenesis</term>
<term>Materials Testing</term>
<term>Mice</term>
<term>Mice, Inbred BALB C</term>
<term>Stem Cell Transplantation</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Animaux</term>
<term>Femelle</term>
<term>Gélatine</term>
<term>Humains</term>
<term>Hydrogel</term>
<term>Lymphangiogenèse</term>
<term>Lymphoedème</term>
<term>Matériaux biocompatibles</term>
<term>Modèles animaux de maladie humaine</term>
<term>Souris</term>
<term>Souris de lignée BALB C</term>
<term>Test de matériaux</term>
<term>Transplantation de cellules souches</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Lymphedema is a manifestation of lymphatic system insufficiency. It arises from primary lymphatic dysplasia or secondary obliteration after lymph node dissection or irradiation. Although improvement of swelling can be achieved by comprehensive non-operative therapy, treatment of this condition requires lifelong care and good compliance. Recently molecular-based treatments using VEGF-C have been investigated by several researchers. We designed the present study to determine whether the therapeutic efficacy of implanted human adipose-derived stem cells (hADSCs) could be improved by applying a gelatin hydrogel containing VEGF-C (VEGF-C hydrogel) to the site of tissue injury in a lymphedema mouse model. Four weeks after the operation, we evaluated edema and determined lymphatic vessel density at various post-operative time points. Mice treated with hADSCs and VEGF-C hydrogel showed a significantly decreased dermal edema depth compared to the groups of mice that received hADSCs only or VEGF-C hydrogel only. Immunohistochemical analysis also revealed that the hADSC/VEGF-C hydrogel group showed significantly greater lymphatic vessel regeneration than all the other groups. hADSCs were detected in the implantation sites of all mice in the hADSC/VEGF-C group, and exhibited a lymphatic endothelial differentiation phenotype as determined by co-staining PKH-labeled hADSCs for the lymphatic marker LYVE-1. Our results suggest that co-administration of hADSCs and VEGF-C hydrogel has a substantial positive effect on lymphangiogenesis.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Corée du Sud</li>
</country>
<region>
<li>Région capitale de Séoul</li>
</region>
<settlement>
<li>Séoul</li>
</settlement>
</list>
<tree>
<noCountry>
<name sortKey="Kim, In Gul" sort="Kim, In Gul" uniqKey="Kim I" first="In Gul" last="Kim">In Gul Kim</name>
<name sortKey="Lee, David S" sort="Lee, David S" uniqKey="Lee D" first="David S" last="Lee">David S. Lee</name>
<name sortKey="Lee, Ji Youl" sort="Lee, Ji Youl" uniqKey="Lee J" first="Ji Youl" last="Lee">Ji Youl Lee</name>
<name sortKey="Lee, Ji Young" sort="Lee, Ji Young" uniqKey="Lee J" first="Ji Young" last="Lee">Ji Young Lee</name>
<name sortKey="Lee, Tae Seung" sort="Lee, Tae Seung" uniqKey="Lee T" first="Tae Seung" last="Lee">Tae Seung Lee</name>
<name sortKey="Piao, Shuyu" sort="Piao, Shuyu" uniqKey="Piao S" first="Shuyu" last="Piao">Shuyu Piao</name>
<name sortKey="Ra, Jeong Chan" sort="Ra, Jeong Chan" uniqKey="Ra J" first="Jeong Chan" last="Ra">Jeong Chan Ra</name>
</noCountry>
<country name="Corée du Sud">
<region name="Région capitale de Séoul">
<name sortKey="Hwang, Ji Hye" sort="Hwang, Ji Hye" uniqKey="Hwang J" first="Ji Hye" last="Hwang">Ji Hye Hwang</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 004A39 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 004A39 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:21421266
   |texte=   Therapeutic lymphangiogenesis using stem cell and VEGF-C hydrogel.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:21421266" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024